Green Hygienics (GRYN) S-1 14 Sep 20 IPO registration Financial data

Cover

Cover	12 Months Ended
	Sep. 30, 2020
Cover [Abstract]
Entity Registrant Name	GREEN HYGIENICS HOLDINGS INC.
Entity Central Index Key	0001443388
Document Type	S-1
Amendment Flag	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Apr. 30, 2020	Jul. 31, 2019	Jul. 31, 2018
Current Assets
Cash	$ 228,237	$ 767	$ 132
Trust funds	0	2,486	0
Prepaids		0	460
Inventory	0	306,450
Total Current Assets	228,237	309,703	592
Deposits		100,000	0
Fixed Assets (Note 3)	4,749,617	145,138
Total Assets	4,977,854	554,841	592
Current Liabilities
Accounts payable and accrued liabilities	683,074	201,178	149,491
Accounts payable - related parties	294,583	57,500	0
Accrued interest payable	21,750	510	0
Deferred revenue	15,973	0
Deferred Loan payable (Note 4a)	24,989	155,250	18,750
Discounted convertible note payable (Note 4c)	221,712	0
SBA loan payable (Note 4b)	444,850	0
Current portion of long-term debt	39,897	0
Due to related parties (Note 8)	1,864,637	780,398	172,961
Total Current Liabilities	3,611,465	1,194,836	341,202
Long Term Liabilities
Agreement payable (less current portion) (Note 5)	119,310	0
Mortgage payable (Note 6)	2,750,000	0
Second Mortgage payable (Note 7)	1,760,000	0
Total Long-Term Liabilities	4,629,310	0
Total Current and Long-Term Liabilities	8,240,775	1,194,836
Nature of operations and continuance of business (Note 1 and 2)	0	0
Commitments (Note 10)	0	0
Subsequent events (Note 11)	0	0
Stockholder's Deficit
Common stock, value	37,949	36,658	34,708
Stock payable	600,000	0
Additional paid-in capital	44,482,731	42,089,489	40,546,930
Deficit	(48,383,601)	(42,766,142)	(40,922,248)
Total Stockholder's Deficit	(3,262,921)	(639,995)	(340,610)
Total Liabilities and Stockholder's Deficit	$ 4,977,854	$ 554,841	$ 592

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 30, 2020	Jul. 31, 2019	Jul. 31, 2018
Stockholder's Deficit
Common stock, shares authorized	375,000,000	375,000,000	375,000,000
Common stock, shares par value	$ 0.001	$ 0.001	$ 0.001
Common stock, shares issued	37,949,502	36,657,835	34,707,835
Common stock, shares outstanding	37,949,502	36,657,835	34,707,835

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019	Jul. 31, 2019	Jul. 31, 2018
Condensed Consolidated Statements of Operations (unaudited)
Rental Revenue	$ 52,800	$ 0	$ 108,574	$ 0
Expenses
Consulting fees (Note 4)	112,000	45,000	390,396	100,000	$ 152,172	$ 120,000
Business development costs	30,000	0	2,471,884	0	1,595,036
Supplies	112,685	0	594,150	0
Sub contracts	18,021	0	138,699	0
Payroll expenses	231,897	0	570,614	0
Inventory impairment expense	306,450	0	306,450	0
General and administrative	264,478	2,096	412,811	12,268	71,303	45,989
Total Expenses	1,075,531	47,096	4,885,004	112,268	1,818,511	165,989
Loss Before Other Income (Expense)	(1,022,731)	(47,096)	(4,776,430)	(112,268)	(1,818,511)	(165,989)
Other Income (Expense)
Depreciation	(21,459)	0	(55,923)	0
Gain on forgiveness of debt					0	39,750
Interest expense	(509,727)	(716)	(785,106)	(2,148)	(25,383)	(2,841)
Total Other Income (Expense)					(25,383)	36,909
Net Income (Loss)	$ (1,553,917)	$ (47,812)	$ (5,617,459)	$ (114,416)	$ (1,843,894)	$ (129,080)
Net Earnings (Loss) Per Share, Basic and Diluted	$ (0.04)	$ 0	$ (0.15)	$ 0	$ (0.05)	$ 0
Weighted Average Shares Outstanding	37,534,687	34,707,835	37,496,856	34,707,835	35,203,862	34,707,835

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019	Jul. 31, 2019	Jul. 31, 2018
Operating Activities
Net loss	$ (1,553,917)	$ (47,812)	$ (5,617,459)	$ (114,416)	$ (1,843,894)	$ (129,080)
Imputed interest			94,833	0	22,009
Inventory impairment			306,450	0
Depreciation expense	21,459	0	55,923	0
Amortization of discount on note payable			365,412	0
Share based compensation			2,421,000	0	1,522,500	0
Changes in operating assets and liabilities:
Prepaid expenses			0	0	460	(460)
Accrued interest payable			21,240	0	510	0
Inventory					306,450	0
Accounts payable and accrued liabilities			435,473	48,013	51,687	64,999
Accounts payable - related party			237,083	0
Deferred revenue			15,973	0
Due to related parties			0	66,459	0	61,924
Net Cash Provided By (Used In) Operating Activities			(1,664,071)	56	(556,178)	(2,617)
Investing Activities
Cash paid for purchase of fixed assets			(118,586)	0	(145,138)
Net Cash Provided by (Used In) Investing Activities			(118,586)	0	(245,138)	0
Financing Activities
Proceeds from Discounted Note Payable			585,000	0
Payments on Discounted Note Payable			(250,000)	0
Proceeds from notes payable			297,638	0	155,250
Proceeds from SBA Loan Payable			444,850
Principle payments on Agreement Payable			(23,825)	0
Principle payments on Defaulted Loan Payable			(130,261)
Advances from related parties			1,084,239		646,187	61,924
Net Cash Provided by Financing Activities			2,007,641	0	801,437	61,924
Increase in cash			224,984	56	3,121	(2,617)
Cash and trust funds, Beginning of Period			3,253	132	132	2,749
Cash and trust funds, End of Period	$ 228,237	$ 188	228,237	188	3,253	132
Supplemental Disclosures:
Interest paid			397,944	0	0	$ 0
Income taxes paid			0	0	0
Non-Cash Transactions
Equipment financed through debt			183,031	0
Land acquired through debt			2,750,000	0
Deposit on acquisition of property			100,000	0	$ (100,000)
Shares issued for conversion of debt			50,000	0
Equipment purchased on accounts payable			46,423
Loan payable transferred to related party			0	18,750
Discount on warrants			$ 428,700	$ 0

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders Deficit (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Stock Payable [Member]
Balance, Shares at Jul. 31, 2017		34,707,835
Balance, amount at Jul. 31, 2017	$ (211,530)	$ 34,708	$ 40,546,930	$ (40,793,168)
Net loss for the year	(129,080)			(129,080)
Net loss	(129,080)
Balance, Amount at Jul. 31, 2018	(340,610)	$ 34,708	40,544,980	(40,922,248)
Balance, shares at Jul. 31, 2018		34,707,835
Net loss for the year	(1,843,894)			(1,843,894)
Imputed interest	22,009		22,009	0
Shares issued for services, shares		1,950,000
Shares issued for services, amount	1,522,500	$ 1,950	1,522,500	0
Net loss	(1,843,894)			(1,843,894)
Balance, Amount at Jul. 31, 2019	(639,995)	$ 36,658	42,089,489	(42,766,142)	$ 0
Balance, shares at Jul. 31, 2019		36,657,835
Imputed interest	94,834		94,834
Shares issued for services, shares		1,125,000
Shares issued for services, amount	1,821,000	$ 1,125	1,819,875
Net loss	(5,617,459)			(5,617,459)
Discount on warrants	428,700		428,700
Shares to be issued for services	600,000				600,000
Shares issued for debt conversion, shares		166,667
Shares issued for debt conversion, amount	50,000	$ 167	49,833
Balance, Amount at Apr. 30, 2020	$ (3,262,921)	$ 37,950	$ 44,482,731	$ (48,383,601)	$ 600,000
Balance, shares at Apr. 30, 2020		37,949,502

Nature of Operations and Contin

Nature of Operations and Continuance of Business	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Nature of Operations and Continuance of Business
Note - 1 Nature of Operations and Continuance of Business	Green Hygienics Holdings Inc. (the “Company”) was incorporated in the State of Nevada on June 12, 2008 as Silver Bay Resources, Inc. On June 30, 2010, the name was changed to Takedown Entertainment Inc. On July 24, 2012, the Company changed its name to Green Hygienics Holdings Inc. The Company is an innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for cannabidiol (“CBD”). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC) making it an ordinary agricultural commodity. The Company’s business model includes generating revenues from the sale of hemp and premium-grade CBD products; creating trusted global consumer brands; developing valuable IP; and growing the Company rapidly through strategic acquisitions. With direct regard to acquisitions, the Company acts as a business accelerator and a vertical integrator focusing to support rapid growth and development of companies with extraordinary potential. On June 10, 2019, the Company secured a multiyear purchase order for the sale of hemp to U.S. Tobacco De Mexico. Under the terms of the contract, the Company is required to deliver a total $56.4 million worth of hemp flower over a five-year period to US Tobacco De Mexico for use in the production of CBD hemp cigarettes. On June 14, 2019, the Company secured from the County of San Diego Department of Agriculture, Weights and Measures, a grower registration for industrial hemp cultivation. On July 22, 2019, the Company secured licenses for the processing of hemp in the state of North Carolina. The licenses were granted to the Company’s newly formed subsidiary, Coastal Labs North Carolina LLC, by the North Carolina Industrial Hemp Commission. The Company’s second subsidiary in the state is Green Hygienics North Carolina LLC, which will be partnering for cultivation this year with the intention of meeting the earnings qualification to be licensed on its own for next year’s cultivation. The Company created Coastal labs and Green Hygienics near the end of July. There was no accounting activity prior to April 30, 2020. The Company’s policy is to consolidate all entities which we control and or own more than 51% of the voting stock. These entities are expected to have accounting activity during subsequent periods and will be consolidated accordingly. On August 26, 2019, the Company completed the acquisition of the 824-acre Potrero Ranch Property near San Diego, California for a total purchase price of $4,510,000. The Company will utilize the land for industrial hemp for CBD cultivation. The property includes over 400,000 square feet of outbuildings which are currently being converted into greenhouses. Going Concern These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated revenues of $108,574 since 2013. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As of April 30, 2020, the Company has a working capital deficiency of $3,383,228 and has an accumulated deficit of $48,383,601 since inception. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.	Green Hygienics Holdings Inc. (the “Company”) was incorporated in the State of Nevada on June 12, 2008 as Silver Bay Resources, Inc. On June 30, 2010, the name was changed to Takedown Entertainment Inc. On July 24, 2012, the Company changed its name to Green Hygienics Holdings Inc. The Company is an innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for cannabidiol (“CBD”). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC) making it an ordinary agricultural commodity. The Company’s business model includes generating revenues from the sale of hemp and premium-grade CBD products; creating trusted global consumer brands; developing valuable IP; and growing the company rapidly through strategic acquisitions. With direct regard to acquisitions, the Company acts as a business accelerator and a vertical integrator focusing to support rapid growth and development of companies with extraordinary potential. On June 10, 2019, the company secured a multiyear purchase order for the sale of hemp to U.S. Tobacco De Mexico. Under the terms of the contract, the Company is required to deliver a total $56.4 million worth of hemp flower over a five year period to US Tobacco De Mexico for use in the production of CBD hemp cigarettes. On June 14, 2019, the Company secured from the County of San Diego Department of Agriculture, Weights and Measures, a grower registration for industrial hemp cultivation. On July 22, 2019, the Company secured licenses for the processing of hemp in the state of North Carolina. The licenses were granted to the Company’s newly formed subsidiary, Coastal Labs North Carolina LLC, by the North Carolina Industrial Hemp Commission. The Company’s second subsidiary in the state is Green Hygienics North Carolina LLC, which will be partnering for cultivation this year with the intention of meeting the earnings qualification to be licensed on its own for next year’s cultivation. The Company created Coastal labs and Green Hygienics near the end of July. There was no accounting activity prior to July 31, 2019. The Company’s policy is to consolidate all entities which we control and or own more than 51% of the voting stock. These entities are expected to have accounting activity during subsequent periods and will be consolidated accordingly. On August 26, 2019, the Company the completed the acquisition of the 824-acre Potrero Ranch Property near San Diego, California for a total purchase price of $4 million. The Company will utilize the land and buildings for industrial hemp for CBD cultivation. The property includes over 400,000 square feet of outbuildings which are currently being converted into greenhouses. Going Concern These financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated revenues since inception and is unlikely to generate earnings in the immediate or foreseeable future. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As at July 31, 2019, the Company has not generated any revenues, has a working capital deficiency of $885,133 and has an accumulated deficit of $42,766,142 since inception. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Significant Accounting Policies
Note - 2 Significant Accounting Policies	(a) Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. (b) Principles of Consolidation These financial statements include the accounts of the Company and its subsidiaries. Subsidiaries are all entities (including structured entities) which the Company controls. For accounting purposes, control is established by an investor when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. All inter-company balances and transactions are eliminated. (c) Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. (d) Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents. (e) Inventory Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. In the current quarter the inventory was fully impaired due to unfavorable weather conditions. In the early growing stages the plants were severely damaged by a sand storm and could not be salvaged. (f) Impairment of Long-Lived Assets The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets (g) Related Party Transactions The Company follows ASC 850, Related Party Disclosures (h) Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. (i) Foreign Currency Translation The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations. (j) Financial Instruments and Fair Value Measures ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. (k) Stock-based Compensation The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. (l) Revenue Pursuant to ASC 606, Revenue from contracts with customers. As of the date of this report, the Company has not recognized any revenue related to the hemp production business. The only revenue recognized to date is the land use rental income from San Diego Gas and Electric Company in the amount of $108,574. The term of the rental agreement is in effect until December 2020 with a monthly payment of $17,000. (m) Leases Pursuant to ASC 842, transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. As of the date of this report, the Company has no material transactions to report. (n) Loss Per Share The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of April 30, 2020, the Company does not have any potentially dilutive shares. (o) Comprehensive Loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. (p) Recent Accounting Pronouncements In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases. Under the new guidance, lessees will be required to recognize for all leases, with the exception of short-term leases, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis. Concurrently, lessees will be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. During the nine months ended April 30, 2020 the Company assessed the impact this guidance had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements.	(a) Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. (b) Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. (c) Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents. (d) Inventory Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. As of the date of this report, no reserve was deemed necessary. (e) Impairment of Long-Lived Assets The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets (f) Related Party Transactions The Company follows ASC 850, Related Party Disclosures (g) Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. (h) Foreign Currency Translation The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations. (i) Financial Instruments and Fair Value Measures ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. (j) Stock-based Compensation The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. (k) Loss Per Share The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at July 31, 2019 and 2018, the Company does not have any potentially dilutive shares. (l) Comprehensive Loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. (m) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Deposits

Deposits	12 Months Ended
	Jul. 31, 2019
Deposits
Note - 3 Deposits	During the year ended July 31, 2019, the Company advanced funds of $100,000 toward the acquisition of property known as the Potrero Ranch. The Company completed the acquisition on August 24, 2019.

Inventory

Inventory	12 Months Ended
	Jul. 31, 2019
Inventory
Note - 4 Inventory	Inventory consists of hemp seeds. Inventory is recorded at cost.

Fixed Assets

Fixed Assets	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Fixed Assets
Note - 5 Fixed Assets	Fixed assets are recorded at cost reduced by accumulated depreciation. Depreciation expense is recognized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted and an impairment assessment may be performed on the recoverability of the carrying amounts. Fixed assets consist of the following: Useful Life Balance at July 31, 2019 $ Additions $ Accumulated Depreciation $ Balance at April 30, 2020 $ Production equipment 5 years 46,379 313,530 (45,733 ) 314,176 Furniture and office equipment 5 years 8,102 - (1,218 ) 6,884 Buildings and improvements 15 years 90,657 134,510 (8,972 ) 216,195 Land - 4,212,362 - 4,212,362 145,138 4,660,402 (55,923 ) 4,749,617 Fixed asset costs are being depreciated using the straight-line method based on the useful life of the asset. On August 26, 2019, the Company completed the acquisition of the 824-acre Potrero Ranch Property near San Diego, California for a total purchase price of $4,510,000. The Company will utilize the land and buildings for industrial hemp for CBD cultivation. The property includes over 400,000 square feet of outbuildings which are currently being converted into greenhouses. On August 23, 2019, the Company entered into an agreement payable with the Vendor of the Property for $2,750,000 for a portion of the purchase price. The terms of the agreement are monthly payments of interest only at the rate of 6% per annum. The debt is secured by a Promissory Note secured by a Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 23, 2024. On August 23, 2019 the Company entered into an agreement payable for $1,760,000 with monthly payments of interest only at the rate of 15% per annum. The debt is secured by a Promissory Note secured by a second charge on the Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 15, 2024.	Fixed assets recorded at cost reduced by accumulated depreciation. Depreciation expense is recognized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted and an impairment assessment may be performed on the recoverability of the carrying amounts. No depreciation has been recorded to date due to immateriality as the assets were acquired near year end. Fixed assets consist of the following: Useful Life Balance at July 31, 2018 Additions Amortization Balance at July 31, 2019 Production equipment 5 years $ - $ 46,379 $ - $ 46,379 Buildings and improvements 15 years - 90,657 - 90,657 Furniture and office equipment 5 years - 8,102 - 8,102 $ - $ 145,138 $ - $ 145,138 Fixed asset costs are being depreciated using the straight-line method based on the useful life of the asset. No depreciation expense has been recorded for the year ended July 31, 2019 due to the immateriality as the assets were acquired near year end.

Loans Payable

Loans Payable	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Loans Payable
Note - 6 Loans Payable	(a) As of April 30, 2020, the Company owes $24,989 (2019 - $nil) plus accrued interest of $301 (2018 - $nil) to a non-related party, which bears interest at the rate of 10% per annum, is unsecured and was due and payable on or before December 19, 2019. This loan payable is in default, and the Company is currently in negotiations to extend the maturity date. (b) On April 30, 2020 the Company received loan proceeds in the amount of $444,850 under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the eight-week period. The unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company intends to use the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will meet the conditions for forgiveness of the loan, we cannot assure you that we will not take actions that could cause the Company to be ineligible for forgiveness of the loan, in whole or in part. (c) As of April 30, 2020, the Company owes $221,712 (2019 - $nil) to a non-related party. On December 19, 2019, the Company entered into an securities purchase agreement, which was amended on January 8, 2020 (collectively, the “SPA”) with Triton Funds, LP, an accredited investor (“Triton”), pursuant to which the Company issued and sold to Triton (i) a discounted convertible promissory note (the “Note”) in the aggregate principal amount of up to $750,000, due June 30, 2020, bearing interest at a rate of ten percent (10%) per annum and convertible into shares of the Company’s common stock at a conversion price of $2.50 per share and (ii) a common stock purchase warrant (the “Warrant”), exercisable for two (2) years, to purchase up to 250,000 shares of the Company’s common stock at an exercise price of $3.00 per share, for an aggregate purchase price of $600,000. If not exercised, the Warrant will expire at 5:00 pm EST on December 31, 2021. The Note can be prepaid at any time by paying 110% of the then outstanding principal, interest, default interest (if any), and any other amounts then due under the Note. The Note is initially convertible at a price per share equal to $2.50 (the “Fixed Conversion Price”); provided, however, that during the continuance of an event of default under the Note, the conversion price shall be equal to 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion. On December 31, 2019, Triton paid an initial purchase price of $100,000 at the initial closing. The Company received net proceeds of $85,000 after paying fees of $15,000. On February 20, 2020, Triton paid the purchase price balance of $500,000, at which point, the Note was payable in the aggregate principal amount of $750,000 and the Warrant was exercisable as to the right to purchase 250,000 shares. The original issue discount on the Note is a total of $150,000. The Note can be prepaid at any time by paying 110% of the then outstanding principal, interest, default interest (if any), and any other amounts then due under the Note. The Note is initially convertible at a price per share equal to $2.50 (the “Fixed Conversion Price”); provided, however, that during the continuance of an event of default under the Note, the conversion price shall be equal to 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion. On March 31, 2020, the Company and Triton entered into a Modification Agreement, pursuant to which (i) the Company paid $250,000 of the principal amount of the Note, bringing the principal balance of the Note to $500,000, (ii) the maturity date of the Note was extended to August 20, 2020, (iii) the conversion price of the Note was established as 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion, and (iv) the minimum volume weighted price requirement of the Note was deleted. As of April 30, 2020, Triton had converted $50,000 of the debt into 166,667 shares which were converted within the terms of the Note. The warrant discount is $166,727 as of April 30, 2020. The Warrants was valued using a Black Scholes model which created a discount of the full value of cash received, bringing the full discount on the note to $428,700, which is to be amortized over the term of the Note. Through April 30, 2020, $261,973 of the discount was amortized, bringing the balance of the note to $221,712. Warrants During the nine months ended April 30, 2020, the Company entered into warrant agreement in conjunction with the note issued by Triton Funds, LP. The warrant provided the right to purchase 250,000 shares of the Company’s common stock at $3 per share exercise. As of the nine months end April 30, 2020 and the year ended July 31, 2019, there were 250,000 and zero warrants outstanding, respectively. The fair value of the warrants granted for the nine months ended April 30, 2020 were determined using Black Scholes method with the following assumptions: Nine months ended April 30, 2020 Risk free interest of 1.62% Stock volatility 338 % Weighted average expected warrant life in years 2 Expected dividend yield 0.00 % Nine months ended April 30, 2020 Year ended July 31, 2019 Warrants Weighted average exercise price Warrants Weighted average exercise price Outstanding-beginning of the year 0 $ 0 0 $ 0 Issued 250,000 $ 3 0 $ 0 Exercised 0 $ 0 0 $ 0 Forfeited 0 $ 0 0 $ 0 Outstanding at respective periods 250,000 $ 3 0 $ 0 Exercisable at each respective period 250,000 $ 3 0 0 Weighted average fair value of warrants granted during the year $ 750,000 Warrant expense for the nine months ended April 30, 2020 and for the year ended July 31, 2019 were $428,700 and $0. The weighted average remaining contractual life of the warrants outstanding as of April 30, 2020 was as follows: Exercise price Number of warrants outstanding Weighted Average remaining contractual life (years) $ 3.00 250,000 1.64	<div style="font: 10pt TIMES NEW ROMAN; text-align: justify;"><div style="LINE-HEIGHT: 11.4pt"><font style="FONT-FAMILY: 'Times New Roman',Times,serif; FONT-WEIGHT: normal">(a) </font><font style="FONT-WEIGHT: normal">As at July 31, 2019, the Company owes $155,250 (2018 - $nil) to a non-related party, which bears interest at the rate of 10% per annum, is unsecured and due and payable on or before December 19, 2019.</font></div></div>

Agreement Payable

Agreement Payable	9 Months Ended
	Apr. 30, 2020
Agreement Payable
Note - 7 Agreement Payable	As of April 30, 2020, the Company owes $159,207 (2018 - $nil) to a non-related party and requires monthly payments of $4,290.40 including interest at the rate of 5.66% per annum for a period of 48 months commencing November 1, 2019. The loan is secured by a collateral charge on production equipment.

Mortgage Payable

Mortgage Payable	9 Months Ended
	Apr. 30, 2020
Mortgage Payable
Note - 8 Mortgage Payable	As of April 30, 2020, the Company owes $2,750,000 (2018 - $nil) to a non-related party, with monthly payments of interest only at the rate of 6% per annum. The debt is secured by a Promissory Note secured by a Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 23, 2024.

Second Mortgage Payable

Second Mortgage Payable	9 Months Ended
	Apr. 30, 2020
Second Mortgage Payable
Note - 9 Second Mortgage Payable	As of April 30, 2020, the Company owes $1,760,000 (2018 - $nil) to a non-related party, with monthly payments of interest only at the rate of 15% per annum. The debt is secured by a Promissory Note secured by a second charge on the Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 15, 2024.

Related Party Transactions

Related Party Transactions	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Loans Payable
Note - 10 Related Party Transactions	(a) As of April 30, 2020, the Company owes $56,824 (July 31, 2019 - $56,824) to a company controlled by the CEO of the Company. The debt bears interest at 5% per annum, is unsecured, and is due on demand. As of April 30, 2020, accrued interest of $16,973 (July 31, 2019 - $14,825) has been included in amounts due to related parties. (b) As of April 30, 2020, the Company owes $1,807,813 (July 31, 2019 - $696,074) to a company controlled by the CEO of the Company. The debt includes funds advanced to the Company for business development purposes, is non-interest bearing, unsecured, and due on demand. (c) As of April 30, 2020, the Company owes $67,500 (July 31, 2019 - $nil) to the CEO of the Company for accrued consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (d) As of April 30, 2020, the Company owes $35,000 (July 31, 2019 - $27,500) to a former director of the Company for accrued consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (e) As of April 30, 2020, the Company owes $67,500 (July 31, 2019 - $15,000) to the CEO of a subsidiary of the Company for consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (f) As of April 30, 2020, the Company owes $67,500 (July 31, 2019 - $15,000) to the President of a subsidiary of the Company for consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (g) As of April 30, 2020, the Company owes $10,000 (July 31, 2019 - $nil) to the CTO of the Company for consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (h) As of April 30, 2020, the Company owes $43,833 (July 31, 2019 - $nil) to the Chief Agricultural Operations Manager of the Company for consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (i) As of April 30, 2020, the Company owes $3,250 (July 31, 2019 - $nil) to the Chief Financial Officer of the Company for consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (j) During the nine months ended April 30, 2020, the Company incurred $67,500 (2019 - $nil) in consulting fees to the CEO of the Company. (k) During the nine months ended April 30, 2020, the Company incurred $22,500 (2019 - $7,500) in consulting fees to the CTO of the Company. (l) During the nine months ended April 30, 2020, the Company incurred $7,500 (2019 - $7,500) in consulting fees to a former VP and former Director of the Company. (m) During the nine months ended April 30, 2020, the Company incurred $67,500 (2019 - $nil) in consulting fees to the President of a subsidiary of the Company. (n) During the nine months ended April 30, 2020, the Company incurred $67,500 (2019 - $nil) in consulting fees to the CEO of a subsidiary of the Company. (o) During the nine months ended April 30, 2020, the Company incurred $7,500 (2019 - $nil) in consulting fees to the CFO of the Company. (p) Imputed interest of $94,833 for the nine months ended April 30, 2020 and $22,009 for the year ended July 31, 2019 has been recorded for the above related party debts.	(a) As at July 31, 2019, the Company owes $56,824 (2018 - $56,824) to a company controlled by the CEO of the Company. The debt bears interest at 5% per annum, is unsecured, and is due on demand. As at July 31, 2019, accrued interest of $14,825 (2018 - $11,961) has been included in accounts payable and accrued liabilities. (b) As at July 31, 2019, the Company owes $696,074 (2018 - $116,137) to a company controlled by the CEO of the Company. The debt includes funds advanced to the Company for business development purposes is non-interest bearing, unsecured, and due on demand. (c) As at July 31, 2019, the Company owes $27,500 (2018 - $nil) to a director of the Company for accrued consulting fees. The debt is non-interest bearing, unsecured, and due on demand and is included in accounts payable. (d) During the year ended July 31, 2019, the Company incurred $30,000 (2018 - $30,000) in consulting fees to a company controlled by the CEO of the Company. (e) During the year ended July 31, 2019, the Company incurred $30,000 (2018 - $nil) in consulting fees to the CTO of the Company. (f) During the year ended July 31, 2019, the Company incurred $27,500 (2018 - $nil) in consulting fees to a VP and Director of the Company. (g) During the year ended July 31, 2019, the Company incurred $15,000 (2018 - $nil) in consulting fees to the President of a subsidiary of the Company. (h) During the year ended July 31, 2019, the Company incurred $15,000 (2018 - $nil) in consulting fees to the CEO of a subsidiary of the Company. (i) Imputed interest of $22,009 was recorded for the above related party debts.

Share Issuances

Share Issuances	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Share Issuances
Note - 11 Share Issuances	(a) During the nine months ended April 30, 2020, the Company issued 250,000 common shares to the CEO of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (b) During the nine months ended April 30, 2020, the Company issued 50,000 common shares to the Chief Agricultural Operations Manager of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (c) During the nine months ended April 30, 2020, the Company issued 200,000 common shares to the Chief Project Manager of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (d) During the nine months ended April 30, 2020, the Company issued 25,000 common shares to the Assistant Agricultural Operations Manager of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (e) During the nine months ended April 30, 2020, the Company issued 300,000 common shares to non-related parties in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (f) During the nine months ended April 30, 2020, the Company agreed to issue 100,000 common shares to an Independent Director of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. The Company issued 50,000 of the shares on April 20, 2020. (g) During the nine months ended April 30, 2020, the Company agreed to issue 250,000 common shares to the Senior Vice President of Corporate Development of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. The Company issued 125,000 of the shares on April 20, 2020. (h) During the nine months ended April 30, 2020, the Company agreed to issue 250,000 common shares to a Senior Vice President of Business Development – Agriculture Division of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. The Company issued 125,000 of the shares on April 20, 2020. (i) During the nine months ended April 30, 2020, the Company issued 166,667 common shares to Triton Funds Inc. in exchange for debt. The shares were valued based on OTC’s closing trade price on the date of the agreement.	(a) During the year ended July 31, 2019, the Company issued 500,000 common shares to the Chief Development Officer of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement. (b) During the year ended July 31, 2019, the Company issued 500,000 common shares to the Business Development Officer of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement. (c) During the year ended July 31, 2019, the Company issued 500,000 common shares to the Chief Technology Officer of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement. (d) During the year ended July 31, 2019, the Company issued 50,000 common shares to the Head of Research and Development of a subsidiary of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement. (e) During the year ended July 31, 2019, the Company issued 200,000 common shares to the Chief Development Officer of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement. (f) During the year ended July 31, 2019, the Company issued 200,000 common shares to the President of a subsidiary of the Company in exchange for services rendered. The shares were valued based on OTC’s closing trade price on the date of the agreement.

Commitments Contingencies

Commitments Contingencies	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Commitments Contingencies
Note - 12 Commitments/Contingencies	(a) On September 1, 2018, the Company entered into a consulting agreement with the CTO, Jeff Palumbo, whereby the Company agreed to pay a consulting fee of $2,500 per month for a period of two years commencing August 1, 2018. The agreement can be extended to four years upon mutual agreement. Upon completion of a minimum $1,000,000 financing, the Company will increase this payment to $5,000 per month. Upon completion of a minimum $5,000,000 financing or profitable operations, the Company will increase this payment to an amount mutually agreed upon that reflects the market rate for services provided by the CTO. (b) On April 1, 2019, the Company entered into a consulting agreement with the Chief Development Officer of the Company, Hamid Rowshan, whereby the Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement. As of April 30, 2020, the Company has not issued any common shares nor expects to issue any common shares in the future due to failure to meet conditions of the consulting agreement. (c) On April 1, 2019, the Company entered into a consulting agreement with the Business Development Officer of the Company, Paymon Omidi, whereby the Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement. As of April 30, 2020, the Company has not issued any common shares nor expects to issue any common shares in the future due to failure to meet conditions of the consulting agreement. (d) On April 1, 2019, the Company entered into a consulting agreement with the Head of Research and Development of a subsidiary of the Company, Kiarash Mirkia. Pursuant to the terms of the agreement, the Company issued the consultant 50,000 common shares upon execution of the agreement. As of April 30, 2020, the Company has not issued any common shares nor expects to issue any common shares in the future due to failure to meet conditions of the consulting agreement. As of April 30, 2020, the Company has not issued any additional common shares nor expects to issue any additional common shares in the future due to failure to meet conditions of the consulting agreement. (e) On June 1, 2019, the Company entered into a consulting agreement with the CEO of a subsidiary of the Company, Kavan Thanasith, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of five years. The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years. As of April 30, 2020, the Company has not issued any common shares nor expects to issue any common shares in the future due to failure to meet conditions of the consulting agreement. (f) On June 1, 2019, the Company entered into a consulting agreement with the President of a subsidiary of the Company, Travis Chrisman, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of five years. The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years. As of April 30, 2020, the Company has not issued any common shares nor expects to issue any common shares in the future due to failure to meet conditions of the consulting agreement. (g) On August 1, 2019, the Company entered into a consulting agreement with the CEO of the Company, Ron Loudoun, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of three years and whereby the Company granted the Consultant an option to acquire 250,000 common shares of the Company or 250,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement for an additional 2 years. (h) On August 1, 2019, the Company entered into a consulting agreement with the Chief Agricultural Operations Manager, Anthony Curci, whereby the Company agreed to pay a signing bonus of $6,000 and a consulting fee of $6,000 per month for a period of nine months. At the end of the six-month period, the Company may evaluate the performance with regards to an extension of the agreement. The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or 25,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement. As of April 30, 2020, the Company has not issued any additional common shares nor expects to issue any additional common shares in the future due to failure to meet conditions of the consulting agreement. (i) On August 1, 2019, the Company entered into a consulting agreement with the Chief Project Manager, Greg Stinson, whereby the Company agreed to pay a signing bonus of $15,000 and a consulting fee of $7,500 per month for a period of five years. The Company also granted the Consultant an option to acquire 100,000 common shares of the Company or 100,000 Options priced at $0.50 per share upon execution of the consulting agreement and an additional 100,000 common shares or Options priced at 10% below market value at the date of grant nine months after the execution of the agreement. As of April 30, 2020, the Company has fulfilled all current obligations under the consulting contract and have been reflected in the Condensed Consolidated Financial Statements. (j) On August 1, 2019, the Company entered into a consulting agreement with the Assistant Agricultural Operations Manager, Carol Snyder, whereby the Company agreed to pay a signing bonus of $4,000 and a consulting fee of $2,000 per month for a period of nine months. At the end of the six-month period, the Company may evaluate the performance with regards to an extension of the agreement. The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or Options at $0.50 per share upon execution of the consulting agreement and an additional 25,000 common shares or Options at 10% below market value at the date of grant nine months after the execution of the agreement. As of April 30, 2020, the Company has fulfilled all current obligations under the consulting contract and have been reflected in the Condensed Consolidated Financial Statements. (k) On February 15, 2020, the Company entered into a consulting agreement with the Chief Financial Officer of the Company, whereby the Company agreed to pay a consulting fee whereby the Company granted the consultant to receive 100,000 common shares for services rendered broken down into two allotment of 50,000 shares, the first at the execution of the agreement and the second six months after the execution of the agreement. These initial shares will be issued in June 2020 at market value of $.50 per share. The Company has the option to extend the consulting agreement for an additional 2 years. As of April 30, 2020, no compensation for the common shares has been recognized under this consulting agreement. (l) On November 15, 2019, the Company entered into a consulting agreement with the Chief Operations Officer, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of three years and, in addition whereby the Company agreed to pay a consulting fee whereby the Company granted the consultant to receive 200,000 common shares for services rendered broken down into two allotment of 100,000 shares, the first at the execution of the agreement and the second six months after the execution of the agreement. These initial shares will be issued in June 2020 at market value of $.50 per share. The Company has the option to extend the consulting agreement for an additional 2 years. As of April 30, 2020, no compensation for the common shares has been recognized under this consulting agreement. (m) On April 1, 2020, the Company entered into a consulting agreement with the Compliance Officer, whereby the Company agreed to pay a consulting fee of $6,000 per month for a period of three years and, in addition whereby the Company agreed to pay a consulting fee whereby the Company granted the consultant to receive 35,000 common shares for services rendered after the execution of the agreement. These common shares will be issued in June 2020 at market value of $.50 per share. The Company has the option to extend the consulting agreement for an additional 2 years. As of April 30, 2020, no compensation for the common shares has been recognized under this consulting agreement. (n) On March 15, 2020, the Company entered into a consulting agreement with the Director of Grow Operations, whereby the Company agreed to pay a consulting fee of $6,000 per month for a period of three years and, in addition whereby the Company agreed to pay a consulting fee whereby the Company granted the consultant to receive 25,000 common shares for services rendered broken down into two allotment of 12,500 shares, the first at the execution of the agreement and the second six months after the execution of the agreement. These initial shares will be issued in June 2020 at market value of $.50 per share. The Company has the option to extend the consulting agreement for an additional 2 years. As of April 30, 2020, no compensation for the common shares has been recognized under this consulting agreement. (o) During the nine months ended April 30, 2020, the Company agreed to issue 50,000 common shares to an Independent Director of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (p) During the nine months ended April 30, 2020, the Company agreed to issue 125,000 common shares to the Senior Vice President of Corporate Development of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. (q) During the nine months ended April 30, 2020, the Company agreed to issue 125,000 common shares to a Senior Vice President of Business Development – Agriculture Division of the Company in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement.	(a)On April 1, 2019, the Company entered into a consulting agreement with the Chief Development Officer of the Company, Hamid Rowshan, whereby the Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement. On April 1, 2019, the Company entered into a consulting agreement with the Business Development Officer of the Company, Paymon Omidi, whereby the Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement. (b) On April 1, 2019, the Company entered into a consulting agreement with the Head of Research and Development of a subsidiary of the Company, Kiarash Mirkia. Pursuant to the terms of the agreement, the Company issued the consultant 50,000 common shares upon execution of the agreement. (c) On June 1, 2019, the Company entered into a consulting agreement with the CEO of a subsidiary of the Company, Kavan Thanasith, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of five years. The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years. (d) On June 1, 2019, the Company entered into a consulting agreement with the President of a subsidiary of the Company, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of five years. The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years.

Income Taxes

Income Taxes	12 Months Ended
	Jul. 31, 2019
Income Taxes
Note - 13 Income Taxes	The Company has net operating losses carried forward of $5,237,753 available to offset taxable income in future years which commence expiring in fiscal 2028. The Company is subject to United States federal and state income taxes at an approximate rate of 26.42% (2018 – 26.42%). The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Company’s income tax expense as reported is as follows: 2019 2018 Income tax recovery at statutory rate (387,218 ) (34,099 ) Change in enacted tax rates - 6,993 Change in valuation allowance 387,218 27,106 Provision for income taxes – – The significant components of deferred income tax assets and liabilities as at July 31, 2019 and 2018 are as follows: 2019 2018 Net operating losses carried forward $ 1,009,928 712,710 Valuation allowance (1,009,928 ) (712,710 ) Net deferred income tax asset – – The 2017 Act reduces the corporate tax rate from 34% to 21% for tax years beginning after December 31, 2017. For net operating losses arising after December 31, 2017, the 2017 Act limits a taxpayer’s ability to utilize net operating losses carryforwards to 80% of taxable income. In addition, net operating losses arising after 2017 can be carried forward indefinitely, but carryback is generally prohibited. Net operating losses generated in tax years beginning before January 1, 2018 will not be subject to the taxable income limitation. The 2017 Act would generally eliminate the carryback of all net operating losses arising in a tax year ending after 2017 and instead would permit all such net operating losses to be carried forward indefinitely. As at July 31, 2019, the Company is in arrears on filing its statutory corporate income tax returns and the amounts presented above are based on estimates. The actual losses available could differ from these estimates.

Subsequent Events

Subsequent Events	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Subsequent Events
Note - 14 Subsequent Events	On May 8, 2020, the Company issued 214,286 common shares to Triton Funds LP upon partial conversion of the Note at the conversion price then in effect. On May 22, 2020, the Company issued 178,571 common shares to Triton Funds LP upon partial conversion of the Note at the conversion price then in effect. On June 8, 2020, the Company issued 153,846 common shares to Triton Funds LP upon partial conversion of the Note at the conversion price then in effect.	(a) On August 23, 2019, a company (Alita Capital Inc.) owned by the President of the Company executed on a Purchase and Sale Agreement to acquire the 824-acre Potrero Ranch Property near San Diego, California (the Agreement”). Alita in advance of the close immediately assigned the Agreement to the Green Hygienics Holdings Inc. The Property now owned fully by Green Hygienics includes 824 acres of land and 400,000 square feet of outbuildings. The total purchase cost of the Property is $4,510,000. The Vendor agreed to a take-back mortgage of $2,750,000 (the ‘Mortgage”) and the Company borrowed $1,760,000 (the “Loan”) by way of a second mortgage to complete the acquisition. The terms of the Mortgage include interest at the rate of 6% per annum with monthly payments of interest only.commencing September 23, 2019. The maturity date of the Mortgage is August 23, 2024. The terms of the Loan include interest at 15% per annum with monthly payments of $22,000 commencing September 15, 2019. The maturity date of the Loan is August 15, 2024. (b) On August 1, 2019, the Company entered into a consulting agreement with the CEO of the Company, whereby the Company agreed to pay a consulting fee of $7,500 per month for a period of three years and whereby the Company granted the Consultant an option to acquire 250,000 common shares of the Company or 250,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement for an additional 2 years. (c) On August 1, 2019, the Company entered into a consulting agreement with the Chief Agricultural Operations Manager whereby the Company agreed to pay a signing bonus of $6,000 and a consulting fee of $6,000 per month for a period of six months. At the end of the six-month period, the Company may evaluate the performance with regards to an extension of the agreement. The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or 25,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement. (d) On August 1, 2019, the Company entered into a consulting agreement with the Chief Project Manager whereby the Company agreed to pay a signing bonus of $15,000 and a consulting fee of $7,500 per month for a period of five years. The Company also granted the Consultant an option to acquire 100,000 common shares of the Company or 100,000 Options priced at $0.50 per share upon execution of the consulting agreement and an additional 100,000 common shares or Options priced at 10% below market value at the date of grant six months after the execution of the agreement. (e) On August 1, 2019, the Company entered into a consulting agreement with the Assistant Agricultural Operations Manager whereby the Company agreed to pay a signing bonus of $4,000 and a consulting fee of $2,000 per month for a period of six months. At the end of the six-month period, the Company may evaluate the performance with regards to an extension of the agreement. The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or Options at $0.50 per share upon execution of the consulting agreement and an additional 25,000 common shares or Options at 10% below market value at the date of grant six months after the execution of the agreement. (f) On August 1, 2019, the Company granted an option to a non-related party to acquire 50,000 common shares of the Company at 10% below market value at the date of grant for services rendered. (g) On September 1, 2018, the Company entered into a consulting agreement with a director of the Company, whereby the Company agreed to pay a consulting fee of $2,500 per month for a period of two years, which can be extended to four years upon mutual agreement. Additionally, the Company will either grant the director 100,000 shares of common stock per year or 100,000 stock options per year to purchase shares of the Company’s common stock priced at 10% below market value at the date of grant. (h) On September 1, 2018, the Company entered into a consulting agreement with the CTO, whereby the Company agreed to pay a consulting fee of $2,500 per month for a period of two years commencing August 1, 2018. The agreement can be extended to four years upon mutual agreement. Upon completion of a minimum $1,000,000 financing, the Company will increase this payment to $5,000 per month. Upon completion of a minimum $5,000,000 financing or profitable operations, the Company will increase this payment to an amount mutually agreed upon that reflects the market rate for services provided by the CTO.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Significant Accounting Policies
Basis of Presentation	These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars.	These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars.
Principles of Consolidation	These financial statements include the accounts of the Company and its subsidiaries. Subsidiaries are all entities (including structured entities) which the Company controls. For accounting purposes, control is established by an investor when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. All inter-company balances and transactions are eliminated.
Use of Estimates	The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.	The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents.	The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents.
Inventory	Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. In the current quarter the inventory was fully impaired due to unfavorable weather conditions. In the early growing stages the plants were severely damaged by a sand storm and could not be salvaged.	Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. As of the date of this report, no reserve was deemed necessary.
Impairment of Long-Lived Assets	The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets	The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets
Related Party Transactions	The Company follows ASC 850, Related Party Disclosures	The Company follows ASC 850, Related Party Disclosures
Income Taxes	The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.	The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Foreign Currency Translation	The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations.	The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations.
Financial Instruments and Fair Value Measures	ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.	ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
Stock-based Compensation	The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.	The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
Revenue	Pursuant to ASC 606, Revenue from contracts with customers. As of the date of this report, the Company has not recognized any revenue related to the hemp production business. The only revenue recognized to date is the land use rental income from San Diego Gas and Electric Company in the amount of $108,574. The term of the rental agreement is in effect until December 2020 with a monthly payment of $17,000.
Leases	Pursuant to ASC 842, transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. As of the date of this report, the Company has no material transactions to report.
Loss Per Share	The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of April 30, 2020, the Company does not have any potentially dilutive shares.	The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As at July 31, 2019 and 2018, the Company does not have any potentially dilutive shares.
Comprehensive Loss	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements.	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements.
Recent Accounting Pronouncements	In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases. Under the new guidance, lessees will be required to recognize for all leases, with the exception of short-term leases, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis. Concurrently, lessees will be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. During the nine months ended April 30, 2020 the Company assessed the impact this guidance had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements.	The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Fixed assets (Table)

Fixed assets (Table)	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Fixed Assets
Schedule of fixed assets	Useful Life Balance at July 31, 2019 $ Additions $ Accumulated Depreciation $ Balance at April 30, 2020 $ Production equipment 5 years 46,379 313,530 (45,733 ) 314,176 Furniture and office equipment 5 years 8,102 - (1,218 ) 6,884 Buildings and improvements 15 years 90,657 134,510 (8,972 ) 216,195 Land - 4,212,362 - 4,212,362 145,138 4,660,402 (55,923 ) 4,749,617	Useful Life Balance at July 31, 2018 Additions Amortization Balance at July 31, 2019 Production equipment 5 years $ - $ 46,379 $ - $ 46,379 Buildings and improvements 15 years - 90,657 - 90,657 Furniture and office equipment 5 years - 8,102 - 8,102 $ - $ 145,138 $ - $ 145,138

Loans Payable (Table)

Loans Payable (Table)	9 Months Ended
	Apr. 30, 2020
Loans Payable
Schedule of fair value of warrants granted	Nine months ended April 30, 2020 Risk free interest of 1.62% Stock volatility 338 % Weighted average expected warrant life in years 2 Expected dividend yield 0.00 %
Schedule of weighted average fair value of warrants granted	Nine months ended April 30, 2020 Year ended July 31, 2019 Warrants Weighted average exercise price Warrants Weighted average exercise price Outstanding-beginning of the year 0 $ 0 0 $ 0 Issued 250,000 $ 3 0 $ 0 Exercised 0 $ 0 0 $ 0 Forfeited 0 $ 0 0 $ 0 Outstanding at respective periods 250,000 $ 3 0 $ 0 Exercisable at each respective period 250,000 $ 3 0 0 Weighted average fair value of warrants granted during the year $ 750,000
Schedule of weighted average remaining contractual life of warrants outstanding	Exercise price Number of warrants outstanding Weighted Average remaining contractual life (years) $ 3.00 250,000 1.64

Income tax (Table)

Income tax (Table)	12 Months Ended
	Jul. 31, 2019
Income Taxes
Schedule of reconciliation of income taxes	2019 2018 Income tax recovery at statutory rate (387,218 ) (34,099 ) Change in enacted tax rates - 6,993 Change in valuation allowance 387,218 27,106 Provision for income taxes – –
Schedule Of deferred income tax assets and liabilities	2019 2018 Net operating losses carried forward $ 1,009,928 712,710 Valuation allowance (1,009,928 ) (712,710 ) Net deferred income tax asset – –

Nature of Operations and Cont_2

Nature of Operations and Continuance of Business (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 26, 2019	Jun. 10, 2019	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019	Jul. 31, 2019	Jul. 31, 2018
Description contract		Under the terms of the contract, the Company is required to deliver a total $56.4 million worth of hemp flower over a five year period to US Tobacco De Mexico for use in the production of CBD hemp cigarettes.
Working capital deficit			$ (3,383,228)		$ (3,383,228)		$ (885,133)
Accumulated Deficit			(48,383,601)		(48,383,601)		(42,766,142)	$ (40,922,248)
Revenue			$ 52,800	$ 0	108,574	$ 0
Purchase price of property							$ (100,000)	$ 0
Additions [Member]
Purchase price of property	$ 4,000,000				$ 4,510,000

Significant Accounting Polici_3

Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019
Revenue	$ 52,800	$ 0	$ 108,574	$ 0
San Diego Gas and Electric Company [Member]
Revenue			$ 108,574
Rental agreement description			The term of the rental agreement is in effect until December 2020 with a monthly payment of $17,000.

Deposits (Details Narrative)

Deposits (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2019	Jul. 31, 2018
Deposits (Details Narrative)
Advanced payment towards acquisition of property	$ (100,000)	$ 0

Fixed Assets (Details)

Fixed Assets (Details) - USD ($)	9 Months Ended		12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jul. 31, 2019
Buildings and improvements	$ 216,195		$ 90,657
Purchase of fixed assets	118,586	$ 0	145,138
Production equipment	314,176		46,379
Furniture and office equipment			8,102
Furniture and office equipment	6,884		8,102
Production equipment			46,379
Land	4,212,362		0
Purchase of fixed assets	4,749,617		$ 145,138
Useful Life [Member]
Purchase of fixed assets	(55,923)
Furniture and office equipment	(1,218)
Production equipment	45,733
Buildings and improvements	(8,972)
Land	$ 0
Buildings and improvements	15 years		15 years
Production equipment	5 years		5 years
Furniture and office equipment, useful life	5 years		5 years
Additions [Member]
Purchase of fixed assets	$ 4,660,402		$ 145,138
Furniture and office equipment			8,102
Furniture and office equipment	0
Production equipment	313,530		46,379
Buildings and improvements	134,510		$ 90,657
Land	$ 4,212,362

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	Jan. 08, 2020	Aug. 26, 2019	Aug. 23, 2019	Apr. 30, 2020
Debt maturity date				Aug. 23, 2024
Triton Funds, LP [Member]
Promissory note issued for acquisition			$ 2,750,000
Interest rate of promissiory note			6.00%
Debt maturity date	Jun. 30, 2019		Aug. 23, 2024
Warrant Agreement [Member] | Triton Funds, LP [Member]
Promissory note issued for acquisition			$ 1,760,000
Interest rate of promissiory note			15.00%
Debt maturity date			Aug. 15, 2024
Additions [Member]
Purchase price of acquisition		$ 4,510,000

Loans Payable (Details)

Loans Payable (Details)	9 Months Ended
	Apr. 30, 2020
Agreement Payable
Risk free interest rate	1.62%
Stock volatility	338.00%
Weighted average expected warrant life	2 years
Expected dividend yield	0.00%

Loans Payable (Details 1)

Loans Payable (Details 1) - Warrant [Member] - USD ($)	9 Months Ended	12 Months Ended
	Apr. 30, 2020	Jul. 31, 2019
Warrants outstanding, beginning	0	0
Warrant, Issued	25,000	0
Warrants, Exercised	0	0
Warrants, Forfeited	0	0
Warrants outstanding, ending	25,000	0
Warrants, Exercisable	25,000	0
Weighted average exercise price, beginning	$ 0	$ 0
Weighted average exercise price, Issued	3	0
Weighted average exercise price, Exercised	0	0
Weighted average exercise price, Forfeited	0	0
Weighted average exercise price, Ending	$ 3	$ 0
Weighted average exercise price, Exercisable	$ 3	$ 0
Weighted average fair value of warrants granted during the year	$ 75,000

Loans Payable (Details 2)

Loans Payable (Details 2) - Warrant [Member]	9 Months Ended
	Apr. 30, 2020$ / sharesshares
Exercise price | $ / shares	$ 3
Number of warrants outstanding | shares	250,000
Weighted average remaining contractual life	1 year 7 months 21 days

Loans Payable (Details Narrativ

Loans Payable (Details Narrative) - USD ($)	Jan. 08, 2020	Mar. 31, 2020	Dec. 31, 2019	Aug. 23, 2019	Apr. 30, 2020	Jul. 31, 2019	Apr. 30, 2019	Jul. 31, 2018	Apr. 30, 2018
Loans payable					$ 24,989	$ 155,250		$ 18,750
Warrants expenses					$ 428,700		$ 0
Maturity date					Aug. 23, 2024
Discounted note payable (Note 4)					$ 221,712	$ 0
Shares issued upon debt conversion, Amount					50,000
Proceeds from SBA Loan Payable					$ 444,850
Common stock issued upon exercise of warrant					37,949,502	36,657,835		34,707,835
Triton Funds, LP [Member]
Maturity date	Jun. 30, 2019			Aug. 23, 2024
Convertible debt	$ 750,000
Warrants issued to purchase shares					250,000
Discounted note payable (Note 4)					$ 261,973		221,712
Original issue discount for the Warrants					$ 166,727
Note payable description					The conversion price shall be equal to 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion.
Net proceeds					$ 85,000
Fees paid					$ 15,000
Interest rate	10.00%
Conversion price	$ 2.50
Initial purchase price			$ 100,000
Purchase price description					The Note can be prepaid at any time by paying 110% of the then outstanding principal, interest, default interest (if any), and any other amounts then due under the Note.
Conversion price of warrants					$ 3
Expiration date					Dec. 31, 2021
Term of warrant					2 years
Common stock issuable upon exercise of warrants, Amount					$ 600,000
Shares issued upon debt conversion, Amount			500,000
Triton Funds, LP [Member] | December 31, 2019 [Member]
Original issue discount for the Warrants					$ 150,000
Term of warrant					48 months
Common stock issuable upon exercise of warrants, Amount					$ 750,000
Common stock issued upon exercise of warrant					250,000
Warrant Agreement [Member] | Triton Funds, LP [Member]
Maturity date				Aug. 15, 2024
Warrants issued to purchase shares					250,000
Exercise price					$ 3
Warrants outstanding					250,000	0
Modification Agreement [Member]
Maturity date		Aug. 20, 2020
Shares issued upon debt conversion		166,667
Convertible debt		$ 50,000
Debt description		The conversion price of the Note was established as 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion			The unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months.
Notes payable, principal amount		$ 250,000	$ 500,000
Paycheck Protection Program [Member]
Debt description					The unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months.
Proceeds from SBA Loan Payable					$ 444,850
Non-related party [Member]
Loans payable					$ 24,989	$ 155,250	0	$ 0
Interest rate					10.00%	0.10%
Accrued interest					$ 301				$ 0
Non-related party One [Member]
Loans payable					$ 221,712		$ 0
Maturity date					Aug. 15, 2024

Agreement Payable (Details Narr

Agreement Payable (Details Narrative) - USD ($)	9 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Agreement payable	$ 159,207	$ 0
Interest rate	6.00%
Triton Funds, LP [Member]
Maturity period	2 years
Triton Funds, LP [Member] | December 31, 2019 [Member]
Interest rate	5.66%
Monthly payments	$ 4,290
Maturity period	48 months

Mortgage Payable (Details Narra

Mortgage Payable (Details Narrative) - USD ($)	9 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Mortgage Payable
Mortgage payable	$ 2,750,000	$ 0
Interest rate	6.00%
Maturity date	Aug. 23, 2024

Second Mortgage Payable (Detail

Second Mortgage Payable (Details Narrative) - USD ($)	9 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Note payable	$ 1,760,000	$ 0
Interest rate	6.00%
Maturity date	Aug. 23, 2024
Non-related party One [Member]
Interest rate	15.00%
Maturity date	Aug. 15, 2024

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Apr. 30, 2020	Apr. 30, 2019	Jul. 31, 2019	Jul. 31, 2018
Imputed interest			$ 94,834		$ 22,009
Consulting fees	$ 112,000	$ 45,000	390,396	$ 100,000	152,172	$ 120,000
Imputed interest			94,833	22,009
CEO Of The Company [Member]
Consulting fees			67,500	0	30,000	30,000
CTO Of The Company [Member]
Consulting fees			22,500	7,500	30,000	0
Due to related parties	10,000	0	10,000	0
VP And Director [Member]
Consulting fees					27,500	0
President Of A Subsidiary Of The Company [Member]
Consulting fees			67,500	0	15,000	0
Due to related parties	67,500	15,000	67,500	15,000	43,833
CEO Of A Subsidiary [Member]
Consulting fees			67,500	0	15,000	0
Due to related parties	$ 56,824	56,824	$ 56,824	56,824
Interest rate	5.00%		5.00%
Accrued interest	$ 16,973	14,825	$ 16,973	14,825
Due to related parties	67,500	15,000	67,500	15,000
Director [Member]
Due to related parties	67,500	0	67,500	0	$ 27,500	$ 0
Interest rate					0.05%	0.05%
Chief Financial Officer [Member]
Consulting fees			7,500	0
Due to related parties	35,000	27,500	35,000	27,500
CEO [Member]
Due to related parties	$ 1,807,813	$ 696,074	1,807,813	696,074	$ 696,074	$ 116,137
Head of Research and Development Of A Subsidiary [Member]
Consulting fees			$ 7,500	$ 7,500

Share Issuances (Details Narrat

Share Issuances (Details Narrative) - shares	9 Months Ended		12 Months Ended
	Apr. 30, 2020	Apr. 20, 2020	Jul. 31, 2019
CEO Of A Subsidiary [Member]
Common stock issued	250,000
Triton Funds, LP [Member]
Common stock issued	166,667
President Of A Subsidiary Of The Company [Member]
Common stock issued	50,000
Independent Director [Member]
Common stock issued	50,000
Senior Vice President [Member]
Common stock issued	125,000
Senior Vice President [Member] | Business Development [Member]
Common stock issued	125,000	125,000
President Of A Subsidiary [Member]
Common stock issued	200,000		200,000
Head of Research and Development Of A Subsidiary [Member]
Common stock issued			50,000
Chief Technology Officer [Member]
Common stock issued			500,000
Business Development Officer [Member]
Common stock issued	25,000		500,000
Chief Development Officer One [Member]
Common stock issued	300,000		200,000
Chief Development Officer [Member]
Common stock issued			500,000

Commitments Contigencies (Detai

Commitments Contigencies (Details Narrative) - USD ($)	1 Months Ended							9 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 15, 2020	Feb. 15, 2020	Nov. 15, 2019	Jun. 01, 2019	May 31, 2019	Apr. 01, 2019	Apr. 30, 2020	Apr. 20, 2020	Jul. 31, 2019	Jul. 31, 2018
Consulting fee per month		$ 6,000
Common stock shares issued								37,949,502		36,657,835	34,707,835
President Of A Subsidiary Of The Company [Member]
Consulting fee per month								$ 6,000
Maturity period								6 months
Consulting agreement description								The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or 25,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement.
Common stock per share price								$ 1.48
Common stock issued								50,000
Common stock shares issued								50,000
CEO Of A Subsidiary [Member]
Consulting agreement description								The Company granted the Consultant an option to acquire 250,000 common shares of the Company or 250,000 Options at 10% below market value at the date of grant upon execution of the consulting agreement for an additional 2 years.
Common stock per share price								$ 1.48
Common stock issued								250,000
CEO Of The Company [Member]
Maturity period						5 years
Consulting agreement description						The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years.
Consulting fee per month						$ 7,500
Common stock shares issued								200,000
Chief Financial Officer [Member]
Consulting fee per month			$ 7,500
Share issued for services			100,000
Shares issued in second installment			50,000
Frequency of periodic payments			Monthly
Initial share issed, share price			$ 0.50
Shares issued in first installment			50,000
CEO [Member]
Consulting fee					$ 7,500
Common shares issued to consultant					200,000
Expense Limitation Agreement Description					The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month.
Head of Research and Development Of A Subsidiary [Member]
Common shares issued to consultant							50,000
Consulting agreement description							The Company issued the consultant 50,000 common shares upon execution of the agreement.
Common stock issued										50,000
Business Development Officer [Member]
Consulting fee per month								$ 2,000
Consulting agreement description							The Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement.	The Company also granted the Consultant an option to acquire 25,000 common shares of the Company or Options at $0.50 per share upon execution of the consulting agreement and an additional 25,000 common shares or Options at 10% below market value at the date of grant nine months after the execution of the agreement.
Common stock per share price								$ 1.48
Share issued for services								50,000
Signing bonus								$ 4,000
Maturity period								6 months
Common stock issued								25,000		500,000
Chief Development Officer [Member]
Consulting agreement description							The Company agreed to pay a to be negotiated consulting fee for an initial period of three months, which can be extended to five years upon mutual agreement.
Share issued for services								50,000
Common stock issued										500,000
Director Of Grow Operations [Member]
Consulting fee per month		$ 6,000
Share issued for services		25,000
Shares issued in second installment		12,500
Term of agreement		3 years
Frequency of periodic payments		Monthly
Initial share issed, share price		$ 0.50
Shares issued in first installment		12,500
Compliance Officer [Member]
Consulting fee per month	$ 6,000
Share issued for services	35,000
Term of agreement	3 years
Frequency of periodic payments	Monthly
Initial share issed, share price	$ 0.50
Chief Operations Officer [Member]
Consulting fee per month				$ 7,500
Share issued for services				200,000
Shares issued in second installment				100,000
Term of agreement				3 years
Frequency of periodic payments				Monthly
Initial share issed, share price				$ 0.50
Shares issued in first installment				100,000
Independent Director [Member]
Common stock issued								50,000
Senior Vice President [Member]
Consulting fee per month								$ 2,500
Term of agreement								2 years
Frequency of periodic payments								Monthly
Common stock issued								125,000
Senior Vice President [Member] | Business Development [Member]
Common stock issued								125,000	125,000
President Of A Subsidiary [Member]
Consulting fee per month						$ 7,500
Consulting fee					$ 7,500
Common shares issued to consultant					200,000
Expense Limitation Agreement Description					The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month.
Consulting fee per month								$ 7,500
Maturity period						5 years		5 years
Agreement to pay bonus								$ 15,000
Consulting agreement description						The monthly fee will increase to: $10,000 per month if the Company generates gross revenue of $1,000,000 per month; $12,500 per month if the Company generates gross revenue of $1,500,000 per month; $15,000 per month if the Company generates gross revenue of $2,000,000 per month and $20,000 per month if the Company generates gross revenue of $2,500,000 per month. The consultant shall also be granted 200,000 common shares per year for a period of five years.		The Company also granted the Consultant an option to acquire 100,000 common shares of the Company or 100,000 Options priced at $0.50 per share upon execution of the consulting agreement and an additional 100,000 common shares or Options priced at 10% below market value at the date of grant nine months after the execution of the agreement.
Common stock per share price								$ 1.48
Common stock issued								200,000		200,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	1 Months Ended	12 Months Ended
	Jun. 01, 2019	Jul. 31, 2019	Jul. 31, 2018
Income tax recovery at statutory rate		$ (34,099)	$ (1,656)
Change in enacted tax rates		6,993	633
Change in valuation allowance		$ 27,106	$ 1,023
CEO [Member]
Common shares issued to consultant	200,000
Consulting fee	$ 7,500

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Jul. 31, 2019	Jul. 31, 2018
Commitments Contigencies (Details Narrative)
Net operating losses carried forward	$ 712,710	$ 712,710
Valuation allowance	$ (712,710)	$ (712,710)

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2019	Jul. 31, 2017
Commitments Contigencies (Details Narrative)
Net operating losse carried forward	$ 3,393,859
Expiring period	2028
Federal and state income tax rate	0.2642%	0.34%
Limits regarding taxpayers	The 2017 Act limits a taxpayer’s ability to utilize net operating losses carryforwards to 80% of taxable income.

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Jun. 08, 2020	May 08, 2020	Jan. 08, 2020	May 22, 2020	Aug. 23, 2019	Apr. 30, 2020	Jul. 31, 2019
Long term debt					$ 1,760,000
Maturity date						Aug. 23, 2024
Triton Funds, LP [Member]
Maturity date			Jun. 30, 2019		Aug. 23, 2024
Common stock shares issuable upon exercise of options						250,000
Exercise price						$ 3
Subsequent Event [Member] | August 1, 2019 [Member] | Non-related party [Member]
Exercise price, description							10% below market value at the date of grant for services rendered
Common stock shares issuable upon exercise of options							25,000
Subsequent Event [Member] | Triton Funds, LP [Member]
Shares issued upon debt conversion	153,846	214,286		178,571
Subsequent Event [Member] | Purchase and sale agreement [Member] | Alita Capital Inc [Member]
Long term debt					$ 1,760,000
Area of land					The Property now owned fully by Green Hygienics includes 824 acres of land and 400,000 square feet of outbuildings.
Property cost					$ 4,510,000
Mortgage cost					$ 2,750,000
Mortgage interest rate					0.06%
Loan monthly payments					$ 22,000
Maturity date					Aug. 15, 2024
Subsequent Event [Member] | Consulting agreement [Member] | CTO [Member] | September 1, 2018 [Member]
Consulting fee payable, periodic payments							$ 2,500
Frequency of periodic payments							Monthly
Description for term of agreement							the Company agreed to pay a consulting fee of $2,500 per month for a period of two years commencing August 1, 2018. The agreement can be extended to four years upon mutual agreement
Conditional increase in cunsulting fees payable periodically							$ 5,000
Description for increase in consulting fees payable							Upon completion of a minimum $1,000,000 financing, the Company will increase this payment to $5,000 per month. Upon completion of a minimum $5,000,000 financing or profitable operations, the Company will increase this payment to an amount mutually agreed upon that reflects the market rate for services provided by the CTO
Subsequent Event [Member] | Consulting agreement [Member] | Director [Member] | September 1, 2018 [Member]
Consulting fee payable, periodic payments							$ 2,500
Frequency of periodic payments							Monthly
Description for term of agreement							the Company agreed to pay a consulting fee of $2,500 per month for a period of two years, which can be extended to four years upon mutual agreement
Description for issuance of shares or options under agreement							Additionally, the Company will either grant the director 100,000 shares of common stock per year or 100,000 stock options per year to purchase shares of the Company’s common stock priced at 10% below market value at the date of grant
Subsequent Event [Member] | Consulting agreement [Member] | Assistant Agricultural Operations Manager [Member] | August 1, 2019 [Member]
Consulting fee payable, periodic payments							$ 2,000
Frequency of periodic payments							Monthly
Exercise price, description							10% below market value at the date of grant six months after the execution of the agreement
Common stock shares issuable upon exercise of options							25,000
Term of agreement							6 months
Signing bonus payable under agreement							$ 4,000
Number of options issuable upon exercise of options at discounted rate							25,000
Exercise price							$ 0.50
Additional common shares or options issuable under agreement							25,000
Subsequent Event [Member] | Consulting agreement [Member] | Chief Agricultural Operations Manager [Member] | August 1, 2019 [Member]
Consulting fee payable, periodic payments							$ 6,000
Frequency of periodic payments							Monthly
Exercise price, description							10% below market value at the date of grant upon execution of the consulting agreement
Common stock shares issuable upon exercise of options							25,000
Term of agreement							6 months
Signing bonus payable under agreement							$ 6,000
Number of options issuable upon exercise of options at discounted rate							25,000
Subsequent Event [Member] | Consulting agreement [Member] | Chief Project Manager [Member] | August 1, 2019 [Member]
Consulting fee payable, periodic payments							$ 7,500
Frequency of periodic payments							Monthly
Exercise price, description							10% below market value at the date of grant six months after the execution of the agreement
Common stock shares issuable upon exercise of options							100,000
Term of agreement							5 years
Signing bonus payable under agreement							$ 15,000
Number of options issuable upon exercise of options at discounted rate							100,000
Exercise price							$ 0.50
Additional common shares or options issuable under agreement							100,000
Subsequent Event [Member] | Consulting agreement [Member] | CEO [Member] | August 1, 2019 [Member]
Consulting fee payable, periodic payments							$ 7,500
Frequency of periodic payments							Monthly
Exercise price, description							10% below market value at the date of grant upon execution of the consulting agreement for an additional 2 years
Common stock shares issuable upon exercise of options							250,000
Term of agreement							3 years
Number of options issuable upon exercise of options at discounted rate							250,000